telmisartan has been researched along with Vascular Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majumdar, A; Nirwane, A; Pawar, V | 1 |
| Krzesinski, JM; Scheen, AJ | 1 |
| Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S | 1 |
| Eder, M; Perl, S; Pressl, H; Schmölzer, I; Sourij, H; Wascher, TC; Zweiker, R | 1 |
| Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S | 1 |
| Ceriello, A; Esposito, K; Giugliano, D; Piconi, L | 1 |
3 trial(s) available for telmisartan and Vascular Diseases
| Article | Year |
|---|---|
[ONTARGET: similar protection of telmisartan and ramipril and lack of benefit of combined therapy in patients at high risk for vascular events].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Humans; Ramipril; Risk Factors; Telmisartan; Treatment Outcome; Vascular Diseases | 2008 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases | 2008 |
Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cross-Over Studies; Double-Blind Method; Female; Glucose Intolerance; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Prospective Studies; Telmisartan; Vascular Diseases | 2010 |
3 other study(ies) available for telmisartan and Vascular Diseases
| Article | Year |
|---|---|
Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Topics: Animals; Aorta, Thoracic; Arsenites; Benzimidazoles; Benzoates; Cardiovascular Agents; Cholesterol; Endothelium, Vascular; Fatty Acids, Omega-3; Glyburide; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Sodium Compounds; Telmisartan; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Diseases; Vasodilation | 2015 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Clopidogrel; Diastole; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Reference Values; Risk; Stroke; Systole; Telmisartan; Ticlopidine; Vascular Diseases | 2011 |
Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Antioxidants; Ascorbic Acid; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Endothelium, Vascular; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Telmisartan; Vascular Diseases | 2007 |